Comparative Oral Bioavailability

Comparative Oral Bioavailability is a pharmacokinetic metric that quantifies and contrasts the systemic availability of a drug following oral administration across different species, normalizing for dose and accounting for interspecies differences in absorption, metabolism, and elimination.

261

Publications

9.8K

Citations

1.2K

Authors

415

Institutions

Publications per year

2017–2026

32

Authors

1.2K

  1. GD
    Gilberto De Nucci

    Universidade Estadual de Campinas (UNICAMP), Brazil

    5 publications · 66 citations

    5

    h-index

  2. JM
    James McAinsh

    AstraZeneca (United Kingdom), United Kingdom

    4 publications · 62 citations

    4

    h-index

  3. JY
    Jean Young

    AstraZeneca (United Kingdom), United Kingdom

    4 publications · 62 citations

    4

    h-index

  4. SC
    Siska Croubels

    Ghent University, Belgium

    4 publications · 209 citations

    4

    h-index

  5. JG
    John G. Wagner

    University of Michigan, United States

    3 publications · 67 citations

    3

    h-index

1–5 of 1.2K

Venues

  1. PubMed

    Repository · 23 publications · 609 citations

    14

    h-index

  2. Journal of Pharmaceutical Sciences

    12 publications · 607 citations

    12

    h-index

  3. Biopharmaceutics & Drug Disposition

    14 publications · 207 citations

    11

    h-index

  4. European Journal of Clinical Pharmacology

    10 publications · 191 citations

    10

    h-index

  5. The Journal of Clinical Pharmacology

    10 publications · 592 citations

    10

    h-index

1–5